Efficacy of L-menthol on Breathlessness in Interstitial Lung Disease

NCT07398287 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Interstitial Lung Disease (ILD)

Interventions

DRUG: L-menthol
OTHER: Placebo

Sponsor

Region Skane

Collaborators

[object Object]
[object Object]
[object Object]